ArticleSignal transduction and targeted therapy2023

RBM4 dictates ESCC cell fate switch from cellular senescence to glutamine-addiction survival through inhibiting LKB1-AMPK-axis.

Lei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.